Table 3 Patients demographic characteristic for 101 E. coli urinary tract isolates during period from January to March 2008
| Â | Total no isolates | Susceptibility to all antibiotic | Resistance to one or more | n (%) isolate resistance to | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Ampicillin | Augmentin | Co-trimoxazole | Ciprofloxacin | Nitofurantoin | Cefazolin | % MDR | ||||
Gender | ||||||||||
 Male | 14 (13.86%) | 4 (28.57%) | 10 (71.42%) | 9 (64.29%) | 2 (14.29%) | 6 (42.86%) | 2 (14.29%) | 1 (7.14%) | 2 (14.29%) | 4 (28.57%) |
 Female | 87 (86.14%) | 28 (32.18%) | 59 (67.82%) | 57 (65.52%) | 12 (13.79%) | 43 (49.43%) | 9 (10.34%) | 2 (2.3%) | 15 (17.24%) | 19 (21.84%) |
 Total | 101 | 32 (31.68%) | 69 (68.31%) | 66 (65.34%) | 14 (13.9%) | 49 (39.60%) | 11 (10.90%) | 3 (3%) | 17 (16.83%) | 23 (22.77%) |
Category of age | ||||||||||
 < 2 years | 7 (6.93%) | 1 (14.29%) | 6 (85.71%) | 6 (85.71%) | 1 (14.29%) | 6 (85.71%) | 0 (0) | 0 (0) | 1 (14.29%) | 1 (14.29%) |
 2 to 6 years | 12 (11.88%) | 3 (25%) | 9 (75%) | 9 (75%) | 2 (16.67%) | 6 (50%) | 0 (0) | 0 (0) | 2 (16.67%) | 2 (16.67%) |
 7 to 12 years | 10 (10%) | 2 (20%) | 8 (80%) | 8 (80%) | 0 | 3 (30%) | 1 (10%) | 0 (0) | 0 (0) | 0 (0) |
 13 to 17 years | 2 (2%) | 1 (50%) | 1 (50%) | 1 (50%) | 0 | 1 (50%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
 18 to 64 years | 48 (47.52%) | 18 (37.5%) | 30 (62.50%) | 28 (58.33%) | 5 (10.42%) | 20 (41.67%) | 4 (8.33%) | 1 (2.08%) | 7 (14.58%) | 9 (18.75%) |
 65 years or more | 22 (21.78%) | 7 (31.82%) | 15 (68.18%) | 14 (63.64%) | 6 (27.27%) | 13 (59.09%) | 6 (27.27%) | 2 (9.09%) | 7 (31.82%) | 11 (50%) |
 Total | 101 | 32 | 69 | 66 | 14 | 49 | 11 | 3 | 17 | 23 |